Trials / Unknown
UnknownNCT01784120
A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate efficacy and toxicity of doxorubicin/Genexol-PM in metastatic breast cancer 1. Primary Purpose: response rate 2. Secondary purpose: toxicity, progression-free survival, overall survival
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxorubicin/Genexol-PM |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-12-01
- First posted
- 2013-02-05
- Last updated
- 2016-02-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01784120. Inclusion in this directory is not an endorsement.